Amgen, Inc.
NASDAQ:AMGN
$67.84
-$0.36
(-0.53%)
Quote as of 4:00 PM EST on 02/14/12
|
$67.84
-$0.36
(-0.53%)
|
|
| Today's Open | $67.84 |
|---|---|
| Previous Close | $68.20 |
| Daily Range | $67.50 - $68.02 |
| 52-Week Range | $47.66 - $70.00 |
| Market Cap | $59.46B |
| P/E Ratio | 12.80 |
| Dividend (Yield) | $1.44 (2.1%) |
| Ex-Dividend Date Dividend Pay Date |
02/13/12 03/07/12 |
| Volume | 4,272,292 |
| Average Daily Volume | 7,070,757 |
| Current FY EPS | $5.95 |
AMGN Information
| Description |
|---|
| A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Make Money in Buyback Achievers the Easy Way
Earnings Preview: DaVita Inc. - Analyst Blog
Random Thoughts: Despite Linsanity, It's Time to Manage Risk
Buzz on the Street: Hurtling Through Chaos
This Just In: More Upgrades and Downgrades
How to Tell if Amgen Is Hiding Weakness
Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary
3 Biotechnology Stocks for Short-Term Traders
When Passing Your Clinical Trial Isn't Enough
24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SI
